Endothelial triple-pathway vasorelaxation as an adjunctive strategy in resistant hypertension. Madeddu P, Cattaneo M, Giuffre M, Laffin LJ, et al. J Hypertens 2026 Mar 20. doi: 10.1097/HJH.0000000000004286.

Read + Share

Amedeo Smart

Independent Medical Education

Madeddu P, Cattaneo M, Giuffre M, Laffin LJ, et al. Endothelial triple-pathway vasorelaxation as an adjunctive strategy in resistant hypertension. J Hypertens 2026 Mar 20. doi: 10.1097/HJH.0000000000004286.
PMID: 41860188